新検索ページはこちら
ログイン
お問い合わせ
（旧版）高血圧治療ガイドライン2004
書誌情報
文献
| 101 ） | MacMahon S, Rodgers A: The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens 1993; 15: 967-978. |
| 102 ） | Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Prospective Studies Collaboration. Lancet 2002; 360: 1903-1913. |
| 103 ） | Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D: Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297. |
| 104 ） | Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: National High Blood Pressure Education Program Coordinating Committee: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252. |
| 105 ） | Takagi S, Saitoh S, Nakano M, Hayashi Y, Obara F, Onishi H, Shimamoto K: Relationship between blood pressure level and mortality rate: an 18-year study conducted in two rural communities in Japan. J Hypertens 2000; 18: 139-144. |
| 106 ） | PROGRESS Collaborative Study Group: Randomised trial of perindopril based blood pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-1041. |
| 107 ） | The Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-153. |
| 108 ） | Zanchetti A, Hansson L, Clement D, Elmfeldt D, Julius S, Rosenthal T, Waeber B, Wedel H; HOT Study Group: Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers? J Hypertens 2003; 21: 797-804. |
| 109 ） | The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial（ALLHAT）. JAMA 2002; 288: 2981-2997. |
| 110 ） | Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N: A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117-1124. |
| 111 ） | Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA: Sodium reduction and weight loss in the treatment of hypertension in older persons. A randomized controlled trial of nonpharmacologic interventions in the elderly（TONE）. JAMA 1998; 279: 839-846. |
| 112 ） | 荒川規矩男：高血圧の運動療法（高血圧のすべて）．医学のあゆみ 1999; 189: 680-684. |
| 113 ） | Hayashi T, Tsumura K, Suematsu C, Okada K, Fujii S, Endo G: Walking to work and risk for hypertension in men: the Osaka Health Survey. Ann Intern Med 1999; 130: 21-26. |
| 114 ） | Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R, Lewis CE, Liebson PR for the Treatment of Hypertension Study Group: Treatment of mild hypertension study. Final results. JAMA 1993; 270: 713-724. |
| 115 ） | Singer DRJ, Markandu ND, Cappuccio FP, Miller MA, Sagnella GA, MacGregor GA: Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide. Hypertension 1995; 25: 1042-1044. |
| 116 ） | Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H; LIFE Study Group: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study（LIFE）: a randomised trial against atenolol. Lancet 2002; 359: 995-1003. |
| 117 ） | Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A; SCOPE Study Group: The Study on Cognition and Prognosis in the Elderly（SCOPE）: principal results of a randomized double-blind intervention trial. J Hypertens 2003; 21: 875-886. |
| 118 ） | Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A; VALUE trial group: Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363: 2022-2031. |
| 119 ） | Weber MA, Julius S, Kjeldsen SE, Brunner HR, Ekman S, Hansson L, Hua T, Laragh JH, McInnes GT, Mitchell L, Plat F, Schork MA, Smith B, Zanchetti A: Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet 2004; 363: 2049-2051. |
| 120 ） | 藤井潤，今鷹耕二：長期療法の維持とコンプライアンス．高血圧の長期治療．中外医学社，東京，1988, pp149-160. |
| 121 ） | Wing LMH, Brown MA, Beilin LJ, Ryan P, Reid CM: ANBP2 Management Committee and Investigators: 'Reverse white-coat hypertension' in older hypertensives. J Hypertens 2002; 20: 639-644. |
| 122 ） | Saito I, Saruta T: Effect of education through a periodic newsletter on persistence with antihypertensive therapy. Hypertens Res 2003; 26: 159-162. |
| 123 ） | Yoshida K, Matsuoka H, Omae T, Fujii J: Patient-hospital relationship and quality of life in elderly patients with hypertension. Hypertens Res 1995; 18: 77-83. |
| 124 ） | Dimenas ES, Wiklund IK, Dahlhof CG, Lindvall KG, Olofsson BK, de Faire UH: Differences in the subjective well-being and symptoms of normotensives, borderline hypertensives and hypertensives. J Hypertens 1989; 7: 885-890. |
| 125 ） | 三上洋，荻原俊男：高齢者の薬物療法とQOL．日老医誌 1999; 36: 186-190. |
| 126 ） | Croog SE, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, Klerman GL, Williams GH: The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314: 1657-1664. |
| 127 ） | Beto JA, Bansal VK: Quality of life in treatment of hypertension. A meta-analysis of clinical trials. Am J Hypertens 1992; 5: 125-133. |
| 128 ） | Hjemdahl P, Wiklund IK: Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise? J Hypertens 1992; 10: 1437-1446. |
| 129 ） | Della Chiesa A, Pfiffner D, Meier B, Hess OM: Sexual activity in hypertensive men. J Hum Hypertens 2003; 17: 515-521. |
| 130 ） | Grimm RH Jr, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, Yunis C, Svendsen K, Liebson PR, Elmer PJ: Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study（TOMHS）. Hypertension 1997; 29: 8-14. |
| 131 ） | Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J: Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993; 328: 914-921. |
| 132 ） | Kloner RA, Brown M, Prisant LM, Collins M: Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group. Am J Hypertens 2001; 14: 70-73. |
| 133 ） | Eaton SB, Eaton SB 3rd, Konner MJ, Shostak M: An evolutionary perspective enhances understanding of human nutritional requirements. J Nutr 1996; 126: 1732-1740. |
| 134 ） | 厚生労働省保健医療局地域保健・健康増進栄養課生活習慣病対策室：平成14年版国民栄養の現状．第一出版，東京，2004. |
| 135 ） | Tochikubo O, Sasaki O, Umemura S, Kaneko Y: Management of hypertension in high school students by using new salt titrator tape. Hypertension 1986; 8: 1164-1171. |
| 136 ） | Fujita T, Ando K, Ogata E: Systemic and regional hemodynamics in patients with salt-sensitive hypertension. Hypertension 1990; 16: 235-244. |
| 137 ） | Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, Inenaga T, Kimura G: Sodium sensitivity and cardiovascular events with essential hypertension. Lancet 1997; 350: 1734-1737. |
| 138 ） | Fujita T, Ando K: Hemodynamic and endocrine changes associated with potassium supplementation in sodium-loaded hypertensives. Hypertension 1984; 6: 184-192. |
| 139 ） | Kawano Y, Matsuoka H, Takishita S, Omae T: Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. Hypertension 1998; 32: 260-265. |
| 140 ） | Iso H, Terao A, Kitamura A, Sato S, Naito Y, Kiyama M, Tanigaki M, Iida M, Konishi M, Shimamoto T, Komachi Y: Calcium intake and blood pressure in seven Japanese population. Am J Epidemiol 1991; 133: 776-783. |
| 141 ） | Zhou BF, Stamler J, Dennis B, Moag-Stahlberg A, Okuda N, Robertson C, Zhao L, Chan Q, Elliott P, for the INTERMAP Research Group: Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the last 1990s: The INTERMAP Study. J Hum Hypertens 2003; 17: 623-630. |
| 142 ） | 松澤佑次，井上修二，池田義雄，坂田利家，齋藤康，佐藤祐造，白井厚治，大野誠，宮崎滋，徳永勝人，深川光司，山之内国男，中村正：新しい肥満の判定と肥満症の診断基準．肥満研究 2000; 6: 18-28. |
| 143 ） | Miyao M, Furuta M, Sakakibara H, Kondo T, Ishihara S, Yamanaka K, Yamada S: Analysis of factors related to hypertension in Japanese middle-aged male workers. J Hum Hypertens 1992; 6: 193-197. |
| 144 ） | Kawamura M, Adachi T, Nakajima J, Fujiwara T, Hiramori K: Factors that affect calorie-sensitive and calorie-insensitive reduction in blood pressure during short-term calorie reduction in overweight women. Hypertension 1996; 27: 408-413. |
| 145 ） | Masuo K, Mikami H, Ogihara T, Tuck ML: Weight reduction and pharmacologic treatment in obese hypertensives. Am J Hypertens 2001; 14: 530-538. |
| 146 ） | Sasaki S, Higashi Y, Nakagawa K, Kimura M, Noma K, Sasaki S, Hara K, Matsuura H, Goto C, Oshima T, Chayama K: A low-calorie diet improves endothelium-dependent vasodilation in obese patients with essential hypertension. Am J Hypertens 2002; 15: 302-309. |
| 147 ） | Hsieh SD, Yoshinaga H, Muto T, Sakurai Y: Regular physical activity and coronary risk factors in Japanese men. Circulation 1998; 97: 661-665. |
| 148 ） | Tashiro E, Miura S, Koga M, Sasaguri M, Ideishi M, Ikeda M, Tanaka H, Shindo M, Arakawa K: Crossover comparison between the depressor effects of low and high work-rate exercise in mild hypertension. Clin Exp Pharmacol Physiol 1993; 20: 689-696. |
| 149 ） | Ishikawa-Takata K, Ohta T, Tanaka H: How much exercise is required to reduce blood pressure in essential hypertensives: a dose-response study. Am J Hypertens 2003; 16: 629-633. |
| 150 ） | Kiyonaga A, Arakawa K, Tanaka H, Shindo M: Blood pressure and hormonal responses to aerobic exercise. Hypertension 1985; 7: 125-131. |
| 151 ） | 日本腎臓学会：腎疾患患者の生活指導・食事療法に関するガイドライン．日腎会誌 1997; 39: 1-37. |
| 152 ） | Motoyama M, Sumani Y, Kinoshita F, Kiyonaga A, Tanaka H, Shindo M, Irie T, Urata H, Sasaki J, Arakawa K: Blood pressure lowering effect of low intensity aerobic training in elderly hypertensive patients. Med Sci Sports Exerc 1998; 30: 818-823. |
| 153 ） | Ohkubo T, Hozawa A, Nagatomi R, Fujita K, Sauvaget C, Watanabe Y, Anzai Y, Tamagawa A, Tsuji I, Imai Y, Ohmori H, Hisamichi S: Effects of exercise training on home blood pressure values in older adults: a randomized controlled trial. J Hypertens 2001; 19: 1045-1052. |
| 154 ） | Ueshima H, Ozawa H, Baba S, Nakamoto Y, Omae T, Shimamoto T, Komachi Y: Alcohol drinking and high blood pressure: Data from a 1980 National Cardiovascular Survey of Japan. J Clin Epidemiol 1992; 45: 667-673. |
| 155 ） | Marmot MG, Elliott P, Shipley MJ, Dyer AR, Ueshima H, Beevers DG, Stamler R, Kestloot H, Rose G, Stamler J: Alcohol and blood pressure: the INTERSALT study. BMJ 1994; 308: 1263-1267. |
| 156 ） | Ueshima H, Mikawa K, Baba S, Sasaki S, Ozawa H, Tsushima M, Kawaguchi A, Omae T, Katayama Y, Kayamori Y, Ito K: Effect of reduced alcohol consumption of native Japanese to American Men. J Clin Epidemiol 1990; 43: 1407-1414. |
| 157 ） | Kiyohara Y, Ueda K, Fujishima M: Smoking and cardiovascular disease in the general population in Japan. J Hypertens 1990; 8（Suppl 5）: S9-S15. |
| 158 ） | Sato I, Nishida M, Okita K, Nishijima H, Kojima S, Matsumura N, Yasuda H: Beneficial effect of stopping smoking on future cardiac events in male smokers with previous myocardial infarction. Jpn Circ J 1992; 56: 217-222. |
| 159 ） | Kim MK, Sasaki S, Sasazuki S, Ohkubo S, Hayashi M, Tsugane S: Lack of long-term effect of vitamin C supplementation on blood pressure. Hypertension 2002; 40: 797-803. |
| 160 ） | Brown BG, Cheung MC, Lee AC, Zhao X-Q, Chait A: Antioxidant vitamins and lipid therapy- End of a long romance? Arterioscler Thromb Vasc Biol 2002; 22: 1535-1546. |
| 161 ） | The Eurowinter Group: Cold exposure and winter mortality from ischemic heart disease, cerebrovascular disease, respiratory disease, and all cause in warm and cold regions of Europe. Lancet 1997; 349: 1341-1346. |
| 162 ） | Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, Vollmer WM, Lin PH, Svetkey LP, Stedman SW, Young DR, Writing Group of the PREMIER Collaborative Research Group: Effects of comprehensive lifestyle modification on blood pressure control. JAMA 2003; 289: 2083-2093. |
| 163 ） | Blood Pressure Lowering Treatment Trialists' Collaboration: Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362: 1527-1535. |
| 164 ） | Staessen JA, Wang JG, Thijs L: Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens 2003; 21: 1055-1076. |
| 165 ） | National Intervention Cooperative Study in Elderly Hypertensives Study Group: Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. Hypertension 1999; 34: 1129-1133. |
| 166 ） | The GLANT Study Group: A 12-month comparison of ACE inhibitor and Ca antagonist therapy in mild to moderate essential hypertension-The GLANT study-. Hypertens Res 1995; 18: 235-244. |
| 167 ） | 斉藤郁夫，河辺博史，猿田享男，鈴木洋通，中村隆一，半田みち子，江口豊寿，影山洋：Ca拮抗薬，ACE阻害薬，β遮断薬による降圧療法の効果．日本医事新報 1994; No 3683: 27-31. |
| 168 ） | Baba S, the J-MIND Study Group: Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetes. Diabetes Res Clin Practice 2001; 54: 191-201. |
| 169 ） | Yui Y, Sumiyoshi T, Kodama K, Hirayama A, Nonogi H, Kanmatsuse K, Origasa H, Iimura O, Ishii M, Saruta T, Arakawa K, Hosoda S, Kawai C, the Japan Multicenter Investigation for Cardiovascular Disease-B（JMIC-B）Study Group: Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: The Japan Multicenter Investigation for Cardiovascular Disease-B（JMIC-B）randomized trial. Hypertens Res 2004; 27: 181-191. |
| 170 ） | Furberg CD, Psaty BM, Meyer JV: Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1231-1232. |
| 171 ） | Hayashi K, Kumagai H, Saruta T: Effect of efonidipine and ACE inhibitors on proteinuria in human hypertension with renal impairment. Am J Hypertens 2003; 16: 116-122. |
| 172 ） | Minami J, Ishimitsu T, Higashi T, Numabe A, Matsuoka H: Comparison between cilnidipine and nisoldipine with respect to effects on blood pressure and heart rate in hypertensive patients. Hypertens Res 1998; 21: 215-219. |
| 173 ） | Kuramoto K, Ichikawa S, Hirai A, Kanada S, Nakachi T, Ogihara T: Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure. Hypertens Res 2003; 26: 201-208. |
| 174 ） | Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GBJ, Miller ME, Riley W: Effect of amlodipine on the progression of atheroscrelosis and the occurrence of clinical events. Circulation 2000; 102: 1503-1510. |
| 175 ） | Goldberg AI, Dunlay MC, Sweet CS: Safety and tolerability of losartan compared with atenolol, felodipine and angiotensin converting enzyme inhibitors. J Hypertens 1995; 13（Suppl 1）: S77-S80. |
| 176 ） | 吉永馨，飯村攻，猿田享男，矢崎義雄，石井當男，水野康，荻原俊男，武田忠直，荒川規矩男，柊山幸志郎，中島光好：本態性高血圧に対するMK-954（losartan potassium）の臨床的有用性の検討．マレイン酸エナラプリルを対照とした二重盲検群間比較試験．医学のあゆみ 1995; 172: 758-823. |
| 177 ） | 荒川規矩男，荻原俊男，飯村攻，阿部圭志，猿田享男，石井當男，日和田邦男，藤島正敏，柊山幸志郎，佐久間昭：本態性高血圧症に対するTCV-116（candesartan cilexetil）の臨床的有用性-マレイン酸エナラプリルを対照とした二重盲検群間比較試験．臨床医薬 1996; 12: 2613-2661. |
| 178 ） | Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy: The Collaborative Study Group. N Engl J Med 1993; 329: 1456-1462. |
| 179 ） | Hasegawa Y, Yamaguchi T, Omae T, Woodward M, Chalmers J, the PROGRESS CT Substudy Investigators: Effects of perindopril-based blood pressure lowering and of patients characteristics on the progression of silent brain infarct: the perindopril protection against recurrent stroke study（PROGRESS）CT substudy in Japan. Hypertens Res 2004; 27: 147-156. |
| 180 ） | 猿田享男，荒川規矩男，飯村攻，阿部圭志，松岡博昭，中野赳，中川雅夫，荻原俊男，梶山悟朗，日和田邦男，藤島正敏，中島光好：高血圧患者に対する塩酸イミダプリルの有用性，特に空咳発現について．マレイン酸エナラプリルを対照とした比較検討-多施設共同，空咳発現頻度調査-．新薬と臨床 1998; 47: 249-282. |
| 181 ） | Shah S, Khatri T, Freis ED: Mechanism of antihypertensive effect of thiazide diuretics. Am Heart J 1998; 95: 611-618. |
| 182 ） | Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J, for the Randomized Aldactone Evaluation Study Investigators: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-717. |
| 183 ） | Saruta T, Kageyama S, Ogihara T, Hiwada K, Ogawa M, Tawara K, Gatlin M, Garthwaite S, Bittman R, Patrick J: Efficacy and safety of the selective aldosterone blocker eplerenone in Japanese patients with hypertension: A randomized, double-blind, placebo-controlled, dose-ranging study. J Clin Hypertens 2004; 6: 175-185. |
| 184 ） | Saruta T, Suzuki H, Kawamura M, Itoh H: Serum creatine phosphokinase levels during treatment with beta-adrenoreceptor blocking agents. J Cardiovasc Pharmacol 1985; 7: 805-808. |
| 185 ） | 後藤由夫，神津康雄，川邊兼美，川上忠志，倉井亮，原俊夫，望月紘一，山口いづみ，矢崎義雄，開原成允，石井當男：高コレステロール血症および糖尿病の一方または双方を合併した本態性高血圧症に対するメシル酸ドキサゾシンの長期効果の検討．日本臨床内科医会会誌 2001; 16: 46-67. |
| 186 ） | 篠原幸人，吉本高志，福内靖男，石神重信，脳卒中合同ガイドライン委員会：脳卒中治療ガイドライン2004．協和企画，東京，2004. |
| 187 ） | Broderick JP, Adams HP Jr, Barsan W, Feinberg W, Feldmann E, Grotta J, Kase C, Krieger D, Mayberg M, Tilley B, Zabramski JM, Zuccarello M: Guidelines for the management of spontaneous intracerebral hemorrhage; a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999; 30: 905-915. |
| 188 ） | Adams HP Jr, Brott TG, Crowell RM, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Marler JR, Woolson RF, Zivin JA, Feinberg W, Mayberg M: Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25: 1901-1914. |
| 189 ） | 栗山良紘：CBF（cerebral blood flow）autoregulation および降圧治療．ACE inhibitors; innovative clinical applications. 猿田享男，荒川規矩男，國府達郎（監修），Medical Tribune, 東京，1990，pp89-96. |
| 190 ） | International Society of Hypertension Writing Group: International Society of Hypertension（ISH）: Statement on the management of blood pressure in acute stroke. J Hypertens 2003; 21: 665-672. |
| 191 ） | Osaki Y, Matsubayashi K, Yamasaki M, Okumiya K, Yoshimura K, Yoshimura K, Hamashige N, Doi Y: Post-stroke hypertension correlates with neurologic recovery in patients with acute ischemic stroke. Hypertens Res 1998; 21: 169-173. |
| 192 ） | Blood Pressure in Acute Stroke Collaboration（BASC）: Interventions for deliberating altering blood pressure in acute stroke. The Cochrane Library, Issue 3, 2003. Update Software, Oxford, 2003. |
| 193 ） | The National Institute of Neurological Disorders and Stroke: Proceedings of national symposium on rapid identification and treatment of acute stroke. NIH publication 1997; No 97-4239: 1-183. |
| 194 ） | Schrader J, Luders S, Kulschewski A, Berger J, Zidek W, Treib J, Einhaupl K, Diener HC, Dominiak P: The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 2003; 34: 1699-1703. |
| 195 ） | Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiakowski TG, Marler JR, Hademenos GJ, Stroke Council of the American Stroke Association: Guidelines for the early management of patients with ischemic stroke. A scientific statement from the stroke council of the American Heart Association. Stroke 2003; 34: 1056-1083. |
| 196 ） | Irie K, Yamaguchi T, Minematsu K, Omae T: The J-curve phenomenon in stroke recurrence. Stroke 1993; 24: 1844-1849. |
| 197 ） | The INDANA project collaborators: Effect of antihypertensive treatment in patients having already suffered from stroke: Gathering the evidence. Stroke 1997; 28: 2557-2562. |
| 198 ） | Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, Chalmers J, PROGRESS Collaborative Group: Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003; 163: 1069-1075. |
| 199 ） | Fransen M, Anderson C, Chalmers J, Chapman N, Davis S, MacMahon S, Neal B, Sega R, Terent A, Tzourio C, Woodward M: Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial. Stroke 2003; 34: 2333-2338. |
| 200 ） | Chapman N, Huxley R, Anderson C, Bousser MG, Chalmers J, Colman S, Davis S, Donnan G, MacMahon S, Neal B, Warlow C, Woodward M: Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history. The PROGRESS trial. Stroke 2004; 35: 116-121. |
